Background. Non-AIDS defining cancers (non-ADCs) have become the leading non-
Introduction
The increasing survival of HIV-infected individuals with access to highly active antiretroviral therapy (HAART) has led to dramatic changes in mortality patterns of people with HIV/AIDS. 1, 2 While mortality rates for AIDS-related conditions have been decreasing over time, those of non-AIDS-related ones remained unchanged or decreased very slightly. [3] [4] [5] In particular, non-AIDS defining cancers (non-ADCs, i.e., cancers other than Kaposi sarcoma, non-Hodgkin lymphoma, and cervix uteri) have become the leading non-AIDS-related causes of death in the late HAART era, among both people with HIV 1, 3 and people with AIDS (PWA). 6 Nonetheless, the risk of death as compared to the HIV-uninfected population is still far from being assessed for each cancer site/type in the late HAART era, as only few studies quantified excess mortality for specific cancers among people with HIV 4 or PWA. 6 In addition, most mortality studies were solely based on the underlying cause of death (i.e., the disease or injury which initiated the train of morbid events leading directly to death), 7 which is poorly informative of the complexity of the morbidity conditions that affect people with HIV/AIDS. Furthermore, such approach does not allow a direct comparison with the uninfected population because most death certificates of people with HIV/AIDS report 'HIV/AIDS' as the underlying cause of death. 6, 8 To overcome such limits, several methods have been used. [3] [4] [5] [6] 8, 9 For instance, in a previous Italian investigation aimed at quantifying the excess cancer mortality among PWA, as compared to the general population, we re-assigned the underlying cause of death by excluding HIV/AIDS reference in the death certificates.
10,11
Currently, the availability in Italy of multiple-cause-of-death (MCoD) data (i.e., all the conditions reported in death certificates -beyond the underlying cause of death) allows 
Methods
This retrospective cohort study is part of a larger epidemiological, population-based, nationwide investigation on the survival and mortality patterns of PWA in Italy. 12 The following data sources were used: 1) the National AIDS Registry (RAIDS) at the National RCoD data (i.e., inclusion of the investigation in the Italian National Statistical Plan according to permission of the Data Protection Authority). 12 The record-linkage procedure was carried out by means of a validated, semi-automated, software application using names, surnames, and dates of birth that were blinded to the operator and removed from the output. 15, 16 In order to guarantee the highest completeness of the record-linkage procedure, we at RAIDS and by a higher propensity of these people to migrate abroad and of being lost to follow-up.
For the aims of this study, 'PWA deaths' were identified by linked records in RAIDS and RCoD, whereas 'non-PWA deaths' were identified by RCoD records not linked with RAIDS.
Furthermore, in order to avoid the inclusion of HIV-infected people in the comparison group, we excluded from the 'non-PWA deaths' category those records reporting AIDS/HIV-related conditions (i.e., ICD-10 codes B20-B24).
To improve comparability between the study groups, the present analysis was restricted to PWA aged 15 to 74 years at diagnosis or at death. Furthermore, we excluded PWA with less than 1 month of follow-up, as the day (within the date) of AIDS diagnosis was often missing; this selection allowed also the exclusion of those PWA diagnosed at death. Our analysis finally included 1229 deaths occurred among 5285 PWA, and 952,019 non-PWA deaths.
Person-years at risk of death for PWA were calculated from the date of AIDS diagnosis to the date of death, or to December 31 st , 2011, whichever came first. PWA who had been diagnosed within 74 years of age but who died thereafter were censored at their 75 th birthday.
The risk of death of PWA, as compared to non-PWA, was estimated using sex-and agestandardized mortality ratios (SMRs). 17 SMRs were calculated as the ratio between the observed number of deceased PWA who had a specific cancer to the expected one, estimated on the basis of sex-and age-specific (quinquennia) mortality rates among non-PWA, multiplied by the person-years at risk among PWA. Mortality rates for non-PWA were computed using, as numerator, the observed number of deceased non-PWA for that specific condition, and, as denominator the average resident Italian population of same sex and age in
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the study period (after the exclusion of Trento and Bolzano provinces, and foreign citizens), as a proxy of person years at risk of death. Corresponding 95% confidence intervals (CIs)
were computed using the exact Poisson method as appropriate for rare events (i.e., ≤5).
18
However, cancer sites with a total number of observed deaths below 4 were reported in the auxiliary Table A (see Supplemental Digital Content, http://links.lww.com/QAI/A820).
Secondary malignancies and malignant neoplasms not otherwise specified (i.e., ICD-10 codes: C77-C80) were not considered in these analyses, as they were almost always (except in 8 cases out of 141 PWA deaths) reported in death certificates together with defined cancers and were, therefore, not relevant for the study aim. Table 1 
Results

Discussion
This study provided nationwide, population-based estimates of the excess cancer mortality among Italian PWA, as compared to people without HIV/AIDS, in the late-HAART era. In addition to extremely elevated risks of death for ADCs, the study documented a statistically significant higher mortality also for cancers not directly associated with HIV/AIDS, with an overall 7.3-fold excess risk for all non-ADCs combined. This latter figure
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can be interpreted as a combination of the increased incidence of such malignancies 15, [19] [20] [21] [22] and of the reduced cancer survival of people with HIV/AIDS. 16, 23, 24 Overall, significant excess mortality emerged for cancers associated with viruses, for which HIV-infected individuals are likely to lose the immune control of infections, and for cancers associated to unhealthy behaviors, like tobacco smoking. All these risk factors have been shown to be more common among HIV-infected individuals than among uninfected ones. 1, 4, 5, 25, 26 Furthermore, mortality in HIV patients without such risk factors was found to be very similar to that of the non-HIV-infected individuals in a Danish cohort. 26 In particular, the poorer survival observed among HIV-infected people via IDU was recently reported to be mostly due to HCV co-infection. 27 In our study, PWA infected via IDU reported also very high SMRs.
As expected, extremely high SMRs were documented for the three ADCs, which were strongly associated with viruses. 28 Very high excess risk emerged also for the group of not otherwise specified uterine cancers where several misclassified cervical cancers are included.
29
Among non-ADCs, very high excess risks were registered for Hodgkin lymphoma (associated to EBV 28 ) and anal carcinoma (associated to HPV 28 ), two cancers that deserve particular attention as the elevated corresponding SMRs were due to the combination of their relative paucity in the general population and to their increased incidence among HIVinfected people. 15, 19, 22 Of note, 2 out of 5 PWA death certificates reporting anal cancer mentioned also Kaposi sarcoma, in line with findings of a large prospective cohort of HIVpositive individuals. 21 This cancer was also found to be more frequent among homosexual PWA 19 (3 out of 5 cases, in our study). Liver cancer, which is strongly associated to infection with hepatitis C and B viruses, 28 showed a particularly high SMR, especially among IDU PWA, similarly to other studies. 19 This tumor was reported together with liver cirrhosis (ICDCopyright Ó 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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10 code K74.6) in 10 out of 17 death certificates (59%) and with chronic viral hepatitis C (HCV, ICD-10 code B18.2) in 5 cases (29%). Highly significant excess risks of death were also seen for lung and head and neck cancers -associated with tobacco smoking-28 in particular among PWA infected through IDU but also among PWA who died at age 50-74 years (an age period in which lung cancer is very common also among the general population 14 ). On the other hand, colorectal cancer, leukemia, and skin melanoma -which also reported significant SMRs-were not generally found to be at increased incidence risk among HIV/AIDS patients. 15, 19 The excess death risk observed for these cancers can be explained by a poorer survival of HIV/AIDS patients after cancer onset. 15, 23 Some misclassification of anal cancer into rectal cancer in death certificates cannot be excluded (SMR=19.0; 95% CI: 7.6-39.1 for rectal cancer, see Table A , Supplemental Digital Content, http://links.lww.com/QAI/A820).
The spectrum of non-ADCs, for which we found excess mortality, and the magnitude of SMRs are in line with our previous investigation 11 and with other studies conducted in highincome countries. Among the main strengths of this study is the use of MCoD data, which allowed direct comparisons with non-PWA for all the conditions contributing to death without the need to
resort to a manual review of death certificates, as customary in earlier studies; 10,11 thus, improving reproducibility. Comparisons based on the underlying cause may be affected by poor detail and would prevent to identify specific conditions. 6, 8 Indeed, in our data 73% (293 cases) of PWA reporting a cancer in death certificate had HIV/AIDS codes as the underlying cause of death (i.e., ICD-10 codes B20-B24) -a value similar to that observed in other investigations, 8 often with a poor level of detail (e.g., 50% had ICD-10 code B22.7="HIV disease resulting in multiple diseases", 7% had unspecific cancer codes B21.7-21.8).
Issues of reliability regarding causes of death derived from death certificate statistics are well known, 30 including a possible lack of specificity and/or underreporting due to the limited knowledge of the certifying physician regarding the medical history of the deceased. This could have differently affected the compilation of death certificates of people with or without HIV infection. Nonetheless, in our investigation, the same coding rules were applied to both study groups, thus limiting information bias.
It is worth remembering that our data included only HIV-infected individuals having already had an AIDS diagnosis. Thus, study results cannot be referred to HIV-infected people at an earlier stage of immunodeficiency. In particular, given that AIDS diagnosis can be a consequence of the diagnosis of an ADC, SMRs for ADCs could be much lower in the case of HIV-infected people without AIDS (in our data, approximately 84% of PWA reporting
ADCs at death reported also ADCs at diagnosis).
The limited number of person-years at risk, resulting in a low number of observed deaths for specific cancer types, was also a study limitation. However, given that most of PWA deaths occurred within the first 6 months after AIDS diagnosis, 12 the median follow-up of 2.5 years was sufficiently long for observing most of the events of interest. Nonetheless, SMRs for very a low number of deaths should be interpreted with caution.
Completeness was the main strength of this investigation. The full coverage of the Italian population by the two used data sources allowed robust comparisons between PWA and the general population. Furthermore, the high sensitivity of the record-linkage procedure, 15, 16 allowed to keep the number of losses to follow-up very limited.
In conclusion, study findings stress the need of monitoring the burden of both virusrelated and non virus-related cancers among PWA in the late HAART era, as they are at still at a higher risk of death than the HIV-negative population. This applies in particular to PWA who acquired HIV infection through IDU. Indeed, our results call for taking primary and secondary preventive actions to reduce both cancer incidence and mortality among people with HIV or AIDS. Using the multiple cause of death data (i.e., each death certificate reports more than one cause), the sum can exceed the total. Causes of death reported in the same death certificate within the same ICD-10 group were counted only once; °S econdary malignant neoplasms or unspecified cancers (C77-80) excluded; ^ It includes also sites/types with less than 4 observed deaths among total PWA, which were not shown in table; § Percentages were calculated on females only.
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